Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Richard F Ambinder

Pharmacologic activation of Lytic Epstein-Barr Virus gene expression without virion production

Lee, J., Kosowicz, J. G., Hayward, S. D., Desai, P., Stone, J., Lee, J. M., Liu, J. O. & Ambinder, R. F., Oct 1 2019, In : Journal of virology. 93, 20, e00998-19.

Research output: Contribution to journalArticle

Pilot trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma

on behalf of the AIDS Malignancy Consortium (AMC), Feb 1 2020, In : Clinical Cancer Research. 26, 3, p. 558-565 8 p.

Research output: Contribution to journalArticle

Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium

Noy, A., Lensing, S. Y., Moore, P. C., Gupta, N., Aboulafia, D., Ambinder, R., Baiocchi, R., Dezube, B. J., Henry, D., Kaplan, L., Levine, A. M., Mitsuyasu, R., Ratner, L., Reid, E., Remick, S., Sparano, J., Tzachanis, D., Wachsman, W. & Chadburn, A., Jul 2 2016, In : Leukemia and Lymphoma. 57, 7, p. 1731-1734 4 p.

Research output: Contribution to journalLetter

Plasma Epstein–Barr virus DNA for screening

Ambinder, R. F., Aug 10 2017, In : New England Journal of Medicine. 377, 6, p. 584-585 2 p.

Research output: Contribution to journalEditorial

Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)

Epeldegui, M., Lee, J. Y., Martínez, A. C., Widney, D. P., Magpantay, L. I., Regidor, D., Mitsuyasu, R., Sparano, J. A., Ambinder, R. F. & Martínez-Maza, O., Jan 15 2016, In : Clinical Cancer Research. 22, 2, p. 328-336 9 p.

Research output: Contribution to journalArticle

Prevalence of HIV in patients with malignancy and of Malignancy in HIV patients in a tertiary care center from north India

Sinha, S., Agarwal, A., Gupta, K., Mandal, D., Jain, M., Detels, R., Nandy, K., Devos, M. A., Sharma, S. K., Manoharan, N., Julka, P. K., Rath, G. K., Ambinder, R. F. & Mitsuyasu, R. T., 2018, In : Current HIV research. 16, 4, p. 315-320 6 p.

Research output: Contribution to journalArticle

Open Access

Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity

Martin, A. R., Pollack, R. A., Capoferri, A., Ambinder, R. F., Durand, C. & Siliciano, R. F., Feb 1 2017, In : Journal of Clinical Investigation. 127, 2, p. 651-656 6 p.

Research output: Contribution to journalArticle

Resistance is futile: Engineering the Adoptive T-Cell therapies of the future

Shenderov, E. & Ambinder, R. F., Apr 10 2018, In : Journal of Clinical Oncology. 36, 11, p. 1140-1142 3 p.

Research output: Contribution to journalShort survey

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

Lee, J. Y., Dhakal, I., Casper, C., Noy, A., Palefsky, J. M., Haigentz, M., Krown, S. E., Ambinder, R. F. & Mitsuyasu, R. T., 2016, In : Journal of Cancer Epidemiology. 2016, 2138259.

Research output: Contribution to journalArticle

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas

AIDS Malignancy Consortium, Dec 26 2018, In : Blood Advances. 2, 24, p. 3618-3626 9 p.

Research output: Contribution to journalArticle

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)

Ramos, J. C., Sparano, J. A., Rudek-Renaut, M., Moore, P. C., Cesarman, E., Reid, E. G., Henry, D., Ratner, L., Aboulafia, D., Lee, J. Y., Ambinder, R. F., Mitsuyasu, R. & Noy, A., Mar 1 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 3, p. 180-190.e2

Research output: Contribution to journalArticle

Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target

Liu, R., Yeh, Y. H. J., Varabyou, A., Collora, J. A., Sherrill-Mix, S., Conover Talbot, C., Mehta, S., Albrecht, K., Hao, H., Zhang, H., Pollack, R. A., Beg, S. A., Calvi, R. M., Hu, J., Durand, C. M., Ambinder, R. F., Hoh, R., Deeks, S. G., Chiarella, J., Spudich, S. & 4 others, Douek, D. C., Bushman, F. D., Pertea, M. & Ho, Y. C., May 13 2020, In : Science translational medicine. 12, 543, eaaz0802.

Research output: Contribution to journalArticle

Open Access

T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy

Keller, M. D., Darko, S., Lang, H., Ransier, A., Lazarski, C. A., Wang, Y., Hanley, P. J., Davila, B. J., Heimall, J. R., Ambinder, R. F., Barrett, A. J., Rooney, C. M., Heslop, H. E., Douek, D. C. & Bollard, C. M., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalArticle

Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: Implications for immunotherapy

Duffield, A. S., Ascierto, M. L., Anders, R. A., Taube, J. M., Meeker, A. K., Chen, S., McMiller, T. L., Phillips, N. A., Xu, H., Ogurtsova, A., Berger, A. E., Pardoll, D. M., Topalian, S. L. & Ambinder, R. F., Jul 25 2017, In : Blood Advances. 1, 17, p. 1324-1334 11 p.

Research output: Contribution to journalArticle

Open Access

The clinical significance of ebv DNA in the plasma and peripheral blood mononuclear cells of patients with or without ebv diseases

Kanakry, J. A., Hegde, A. M., Durand, C. M., Massie, A. B., Greer, A. E., Ambinder, R. F. & Valsamakis, A., Apr 21 2016, In : Blood. 127, 16, p. 2007-2017 11 p.

Research output: Contribution to journalArticle

Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre-and post-transplantation cyclophosphamide

Lombardi, L. R., Kanakry, C. G., Zahurak, M., Durakovic, N., Bolaños-Meade, J., Kasamon, Y. L., Gladstone, D. E., Matsui, W., Borrello, I., Huff, C. A., Swinnen, L. J., Brodsky, R. A., Ambinder, R. F., Fuchs, E. J., Rosner, G. L., Jones, R. J. & Luznik, L., Mar 3 2016, In : Leukemia and Lymphoma. 57, 3, p. 666-675 10 p.

Research output: Contribution to journalArticle

Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes

Hunter, N. B., Vogt, S. & Ambinder, R. F., Dec 15 2017, In : Oncology (Williston Park, N.Y.). 31, 12

Research output: Contribution to journalReview article

Tumor-infiltrating macrophages in post-transplant, relapsed classical Hodgkin lymphoma are donor-derived

Crane, G. M., Samols, M. A., Morsberger, L. A., Yonescu, R., Thiess, M. L., Batista, D., Ning, Y., Burns, K., Vuica-Ross, M., Borowitz, M. J., Gocke, C., Ambinder, R. F. & Duffield, A. S., Sep 1 2016, In : PLoS One. 11, 9, e0163559.

Research output: Contribution to journalArticle

Unveiling Kaposi sarcoma viral antigens

Lee, J., Kosowicz, J. G. & Ambinder, R. F., Feb 7 2017, In : Oncotarget. 8, 31, p. 50325-50326 2 p.

Research output: Contribution to journalComment/debate

Virus-Associated Lymphoma

Kanakry, J. A. & Ambinder, R. F., Jan 1 2018, Hematology: Basic Principles and Practice. Elsevier Inc., p. 1318-1329.e3

Research output: Chapter in Book/Report/Conference proceedingChapter